Direct-acting antivirals for patients with chronic hepatitis C and hepatocellular carcinoma in Taiwan

Direct-acting antivirals for patients with chronic hepatitis C and hepatocellular carcinoma in Taiwan

Background/purpose: The treatment of chronic hepatitis C (CHC) has evolved from interferon (IFN)-based therapy to direct acting antivirals (DAAs). The effect of antiviral treatment on outcome of hepatocellular carcinoma (HCC) patients with CHC has not been well analyzed in Taiwan. Methods: From Apri...

Full description

Bibliographic Details
Main Authors: Chen-Ta Chi, Chi-Yi Chen, Chien-Wei Su, Po-Yueh Chen, Chi-Jen Chu, Keng-Hsin Lan, I-Cheng Lee, Ming-Chih Hou, Yi-Hsiang Huang
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:Journal of Microbiology, Immunology and Infection
Subjects:
DAA
HCC
Interferon
Recurrence
SVR
Online Access:http://www.sciencedirect.com/science/article/pii/S1684118219301574

Internet

http://www.sciencedirect.com/science/article/pii/S1684118219301574

Similar Items